Sign in

CIK 0001549595

  • Large accelerated filer

Nurix Therapeutics, Inc.

Sign in to watch
Ticker
NRIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Nov 30
Incorporated
DE
Entity type
Operating
EIN
270838048
Phone
+1 415-660-5320
Business address
1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
Former names
Nurix, Inc.
  1. 4 Open-market sale Chief Financial Officer sold 697 shares at $11.75 ($8,190)
  2. 4 Open-market sale General Counsel sold 660 shares at $11.75 ($7,755)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Open-market sale General Counsel sold 1,200 shares at $27.14 ($32,568)
  9. 4 Open-market sale Chief Scientific Officer sold 1,828 shares at $28.96 ($52,939)
  10. 4 Open-market sale General Counsel sold 1,200 shares at $29.04 ($34,848)
  11. 4 Open-market sale Chief Scientific Officer sold 400 shares at $29.13 ($11,652)
  12. 4 Open-market sale General Counsel sold 1,200 shares at $32.38 ($38,856)
  13. 4 Open-market sale Chief Scientific Officer sold 400 shares at $33.24 ($13,296)
  14. 4 Open-market sale General Counsel sold 800 shares at $35.25 ($28,200)
  15. 4 Open-market sale Chief Scientific Officer sold 400 shares at $35.00 ($14,000)
  16. 4 Open-market sale General Counsel sold 1,200 shares at $27.36 ($32,832)
  17. 4 Open-market sale Chief Scientific Officer sold 400 shares at $29.92 ($11,968)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 10 of 14 · 274 filings